HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)
- Edo J Dongelmans*
- , Lesley A Patmore
- , Seng Gee Lim
- , Marc Bourliere
- , Shaowen Jiang
- , Nathalie Ganne-Carrie
- , Willem-Pieter Brouwer
- , Jordan J Feld
- , Yuxian Huang
- , Jose A Carrion
- , Teresa Broquetas
- , Qiankun Hu
- , Scott Fung
- , Fabrice Carrat
- , Fabien Zoulim
- , Bettina E Hansen
- , Qing Xie
- , Harry L A Janssen
- , Milan J Sonneveld
*Corresponding author for this work
- Erasmus University Medical Centre
- National University Health System
- Hepatology and Gastroenterology Unit - Liver Unit
- Shanghai Jiao Tong University School of Medicine
- Service d'Hépatologie
- University Health Network
- Fudan University
- Hospital del Mar
- Sorbonne Université
- Lyon Hepatology Institute (IHU EVEREST)
- Toronto General Hospital
- University of Toronto
Research output: Contribution to journal › Article › Academic › peer-review
3
Citations
(Scopus)
5
Downloads
(Pure)